EurekaMag.com logo
+ Site Statistics
References:
47,893,527
Abstracts:
28,296,643
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Prescription trends in children with pervasive developmental disorders: a claims data-based study in Japan


, : Prescription trends in children with pervasive developmental disorders: a claims data-based study in Japan. World Journal of Pediatrics 12(4): 443-449

The only drug approved for pervasive developmental disorders (PDD) in Japan is pimozide. Several psychotropic drugs are also prescribed for offlabel use in Japan, but details regarding their prescription and use are largely unknown. The purpose of this study was to clarify the use of drug treatment in Japanese children with PDD. Data were extracted from claims data from the Japan Medical Data Center for children younger than 18 years of age who were newly diagnosed with PDD (International Classification of Diseases version 10 codes: F84) from 2005 to 2010 (total of 3276 patients as of 2010). The prescription rates were presented as the percentage of PDD patients who were prescribed each drug. Prior to 2010, the prescription rates for atypical antipsychotics, other antipsychotics, psychostimulants, all other central nervous system drugs, anticovnvulsants, non-barbiturates, and Parkinson's disease/syndrome drugs significantly increased among the Anatomical Therapeutic Chemical classifications defined as the "nervous system" (trend P≤0.02). The prescription rate for risperidone consistently increased, reaching 6.9% in 2010 (trend P<0.0001), the highest rate of the surveyed drugs among the antipsychotics. The prescription rate for aripiprazole also increased (trend P<0.0001), reaching 1.9% in 2010. The prescription rate for pimozide showed no annual changes, with a low rate of 0.4% in 2010. Compared with pimozide, the prescription rates for risperidone, aripiprazole and other psychotropic drugs have increased. Because safety data for these drugs in Japanese children are sparse, there is a need for future safety evaluations of these drugs in Japanese children.


Accession: 058610380

PMID: 27286689

DOI: 10.1007/s12519-016-0036-8

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Katada, H.; Yukawa, N.; Urushihara, H.; Tanaka, S.; Mimori, T.; Kawakami, K., 2016: Prescription patterns and trends in anti-rheumatic drug use based on a large-scale claims database in Japan. This drug utilization study aimed to investigate prescription patterns and trends for anti-rheumatic drug use in Japanese patients with rheumatoid arthritis (RA), clarifying if patients with RA in Japan are being treated according to EULAR recomme...

Linderman, T.M.; Stewart, K.B., 1999: Sensory integrative-based occupational therapy and functional outcomes in young children with pervasive developmental disorders: a single-subject study. This single-subject study explored the effects of sensory integrative-based occupational therapy provided in an outpatient clinic on the functional behaviors of two young children with pervasive developmental disorder (PDD) at home. The participan...

Ito, H.; Tani, I.; Yukihiro, R.; Adachi, J.; Hara, K.; Ogasawara, M.; Inoue, M.; Kamio, Y.; Nakamura, K.; Uchiyama, T., 2012: Validation of an interview-based rating scale developed in Japan for pervasive developmental disorders. The pervasive developmental disorders (PDDs) Autism Society Japan Rating Scale (PARS), an interview-based instrument for evaluating PDDs, has been developed in Japan with the aim of providing a method that (1) can be used to evaluate PDD symptoms...

Gevers, C.; Clifford, P.; Mager, M.; Boer, F., 2006: Brief report: A theory-of-mind-based social-cognition training program for school-aged children with pervasive developmental disorders: an open study of its effectiveness. Persons with trisomy 21 (T21) and Williams-Beuren syndrome (WBS) have different brain abnormalities which may affect manual laterality. We assessed 45 persons with T21 and 34 with WBS (mean age 13) and 81 typically developing children (TD). Manual...

Nagata, M.; Tsutsumi, A.; Umene-Nakano, W.; Nakamura, J.; Mori, K., 2012: Frequency of pervasive developmental disorders and supports for workers with pervasive developmental disorders in workplaces: a field survey of psychiatrists well acquainted with occupational practices. In recent years, cases in which occupational health professionals find workers who have or are suspected of having pervasive developmental disorders (PDD) among the persons with poor mental health status have been reported. In this study, to inves...

Greaves-Lord, K.; Eussen, M.L.J.M.; Verhulst, F.C.; Minderaa, R.B.; Mandy, W.; Hudziak, J.J.; Steenhuis, M.Peter.; de Nijs, P.F.; Hartman, C.A., 2014: Empirically based phenotypic profiles of children with pervasive developmental disorders: interpretation in the light of the DSM-5. This study aimed to contribute to the Diagnostic and Statistical Manual (DSM) debates on the conceptualization of autism by investigating (1) whether empirically based distinct phenotypic profiles could be distinguished within a sample of mainly c...

Najdowski, A.C.; Chilingaryan, V.; Bergstrom, R.; Granpeesheh, D.; Balasanyan, S.; Aguilar, B.; Tarbox, J., 2010: Comparison of data-collection methods in a behavioral intervention program for children with pervasive developmental disorders: a replication. Cummings and Carr (2009) compared two methods of data collection in a behavioral intervention program for children with pervasive developmental disorders: collecting data on all trials versus only the first trial in a session. Results showed that...

Luteijn, E.F.; Serra, M.; Jackson, S.; Steenhuis, M.P.; Althaus, M.; Volkmar, F.; Minderaa, R., 2000: How unspecified are disorders of children with a pervasive developmental disorder not otherwise specified? A study of social problems in children with PDD-NOS and ADHD. This study examines possible differences and similarities between social behaviour problems in children with problems classified as pervasive developmental disorder not otherwise specified (PDD-NOS) and a group of children with problems classified...

Tanaka, K.; Horiguchi, T.; Inagaki, M.; Kaga, M., 2004: Guidelines for medical examination of children with mental retardation in pediatric clinics which are specialized for developmental disorders - Recommendation based on the current selection and usefulness of diagnostic examinations for children with mental retardation and/or pervasive developmental disorder. We assessed the present status of choice and usefulness of medical examinations of children with mental retardation (MR) and/or pervasive developmental disorder (PDD). Children with severe MR received more examinations than those with mild MR. Man...

Tanaka, K.; Horiguchi, T.; Inagaki, M.; Kaga, M., 2004: Guidelines for medical examination of children with mental retardation in pediatric clinics which are specialized for developmental disorders--recommendation based on the current selection and usefulness of diagnostic examinations for children with mental retardation and/or pervasive developmental disorder. We assessed the present status of choice and usefulness of medical examinations of children with mental retardation (MR) and/or pervasive developmental disorder (PDD). Children with severe MR received more examinations than those with mild MR. Man...